Amgen challenges Alexion Pharma blood disorder treatment Soliris in US patent court Medical Dialogues Bureau2 Sep 2019 4:00 AM GMTThe IPR is seeking to invalidate new patents covering the composition of the main ingredient of Soliris, eculizumab, its formulation, and its use to...
Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder Medical Dialogues Bureau7 May 2019 3:55 AM GMTThe drug, Ruzurgi, was approved for use in patients aged between 6 and 17, the FDA said Lambert-Eaton myasthenic syndrome, which affects about three...